Nonalcoholic fatty liver disease during valproate therapy
- 30 January 2009
- journal article
- case report
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 168 (11) , 1391-1394
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsyEpilepsy Research, 2007
- Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imagingActa Paediatrica, 2006
- Effects of Weight Loss Surgeries on Liver DiseaseSeminars in Liver Disease, 2004
- Use and Abuse of HOMA ModelingDiabetes Care, 2004
- Valproate therapy and nonalcoholic fatty liver diseaseAnnals of Neurology, 2004
- Evaluation of HOMA and QUICKI as measures of insulin sensitivity in prepubertal childrenPediatric Diabetes, 2003
- Drugs and SteatohepatitisSeminars in Liver Disease, 2002
- Valproate, lamotrigine, and insulin‐mediated risks in women with epilepsyAnnals of Neurology, 1998
- Obesity and endocrine disorders in women taking valproate for epilepsyAnnals of Neurology, 1996
- Variations in pattern of pubertal changes in girls.Archives of Disease in Childhood, 1969